{"component": "definition", "props": {"groups": [{"snippet_links": [{"key": "in-clause", "type": "clause", "offset": [28, 37]}], "snippet": "has the meaning given to it in clause 3.2;", "size": 6, "samples": [{"hash": "1dBgTGQXFvw", "uri": "/contracts/1dBgTGQXFvw#upfront-consideration", "label": "License and Collaboration Agreement (Spring Bank Pharmaceuticals, Inc.)", "score": 31.7460651398, "published": true}, {"hash": "gXbiZmcvTWG", "uri": "/contracts/gXbiZmcvTWG#upfront-consideration", "label": "Share Purchase Agreement (Spring Bank Pharmaceuticals, Inc.)", "score": 29.7460651398, "published": true}, {"hash": "l7IOkm7QVik", "uri": "/contracts/l7IOkm7QVik#upfront-consideration", "label": "License and Collaboration Agreement (Denali Therapeutics Inc.)", "score": 28.8658447266, "published": true}], "hash": "18f4a1cecb9cf8e536bc776c300d34bd", "id": 1}, {"snippet_links": [{"key": "section-22", "type": "clause", "offset": [14, 25]}], "snippet": "is defined in Section 2.2.", "size": 3, "samples": [{"hash": "iJCjS2utWpq", "uri": "/contracts/iJCjS2utWpq#upfront-consideration", "label": "Stock Purchase Agreement", "score": 31.3408622742, "published": true}, {"hash": "48rosGGDvKf", "uri": "/contracts/48rosGGDvKf#upfront-consideration", "label": "Stock Purchase Agreement (Durata Therapeutics, Inc.)", "score": 23.472278595, "published": true}, {"hash": "5FuVDO85koe", "uri": "/contracts/5FuVDO85koe#upfront-consideration", "label": "Stock Purchase Agreement (Durata Therapeutics, Inc.)", "score": 23.327173233, "published": true}], "hash": "4ee7eda26dfe6b7fc079c925b48b24a1", "id": 2}, {"snippet_links": [], "snippet": "has the meaning ascribed to such term in Section 1.02.", "size": 2, "samples": [{"hash": "2WK38I6HjK4", "uri": "/contracts/2WK38I6HjK4#upfront-consideration", "label": "Stock Purchase Agreement (Spero Therapeutics, Inc.)", "score": 28.742641449, "published": true}, {"hash": "fVJRk2jAXhx", "uri": "/contracts/fVJRk2jAXhx#upfront-consideration", "label": "Stock Purchase Agreement (Spero Therapeutics, Inc.)", "score": 28.7234764099, "published": true}], "hash": "dce00ec48e66e7fe0b4093702ce1b680", "id": 3}, {"snippet_links": [{"key": "the-non", "type": "clause", "offset": [6, 13]}], "snippet": "means the non-refundable, non-creditable amount of $5,000,000, $2,000,000 of which is designated as the \u201cNDA Payment.\u201d", "size": 2, "samples": [{"hash": "2oiDfZgHsq1", "uri": "/contracts/2oiDfZgHsq1#upfront-consideration", "label": "Asset Purchase Agreement (Brickell Biotech, Inc.)", "score": 33.3340187073, "published": true}, {"hash": "hTMExnkinOK", "uri": "https://ir.frtx.com/sec-filings/all-sec-filings/content/0000819050-22-000026/0000819050-22-000026.pdf", "label": "ir.frtx.com", "score": 11.1670093536, "published": false}], "hash": "41bca9985380f3ead68aec0e37b4a4c2", "id": 4}, {"snippet_links": [{"key": "purchase-price", "type": "clause", "offset": [49, 63]}], "snippet": "has the meaning set forth in Section 1.3(a)(ii) (Purchase Price).", "size": 2, "samples": [{"hash": "fuwhkOM2MvO", "uri": "/contracts/fuwhkOM2MvO#upfront-consideration", "label": "Asset Purchase Agreement (Q32 Bio Inc.)", "score": 37.1861738535, "published": true}, {"hash": "fYgMkpdL9eM", "uri": "/contracts/fYgMkpdL9eM#upfront-consideration", "label": "Asset Purchase Agreement (Akebia Therapeutics, Inc.)", "score": 37.1533203125, "published": true}], "hash": "f8577e60b3eae02f601152f1c5380478", "id": 5}, {"snippet_links": [{"key": "base-purchase-price", "type": "definition", "offset": [14, 33]}, {"key": "liability-amount", "type": "clause", "offset": [56, 72]}, {"key": "the-closing", "type": "definition", "offset": [79, 90]}], "snippet": "means (a) the Base Purchase Price, less (b) the Blocker Liability Amount as of the Closing.", "size": 2, "samples": [{"hash": "iQwFOPmVnqA", "uri": "/contracts/iQwFOPmVnqA#upfront-consideration", "label": "Securities Purchase Agreement (At&t Inc.)", "score": 35.7460632324, "published": true}, {"hash": "4JK9H7AxXbY", "uri": "/contracts/4JK9H7AxXbY#upfront-consideration", "label": "Securities Purchase Agreement (At&t Inc.)", "score": 33.8254623413, "published": true}], "hash": "fbbe6764dfb0ed3d7259beae675f5e46", "id": 6}, {"snippet_links": [{"key": "sum-of", "type": "clause", "offset": [10, 16]}, {"key": "upfront-cash-consideration", "type": "definition", "offset": [25, 51]}, {"key": "stock-consideration", "type": "clause", "offset": [75, 94]}], "snippet": "means the sum of (i) the Upfront Cash Consideration, plus (ii) the Upfront Stock Consideration.", "size": 2, "samples": [{"hash": "aaJ8EAO01XN", "uri": "/contracts/aaJ8EAO01XN#upfront-consideration", "label": "Agreement and Plan of Merger (SomaLogic, Inc.)", "score": 33.566734314, "published": true}], "hash": "7dc28329f94866f568a6dfc8c004e56f", "id": 7}, {"snippet_links": [], "snippet": "means $80,000,000.", "size": 1, "samples": [{"hash": "aNwFSPKfv5c", "uri": "/contracts/aNwFSPKfv5c#upfront-consideration", "label": "Share Purchase Agreement (Endeavour Silver Corp)", "score": 36.2525672913, "published": true}], "hash": "53d896a5bac2cddf10cde3f286ca0435", "id": 8}, {"snippet_links": [{"key": "offered-by", "type": "definition", "offset": [14, 24]}, {"key": "eligible-investor", "type": "definition", "offset": [30, 47]}, {"key": "the-property", "type": "clause", "offset": [52, 64]}, {"key": "financial-offer", "type": "definition", "offset": [112, 127]}, {"key": "provided-that", "type": "clause", "offset": [161, 174]}], "snippet": "means the sum offered by each Eligible Investor for the Property, whose exact amount shall be determined in his Financial Offer or his Improved Financial Offer (provided that the", "size": 1, "samples": [{"hash": "9YG4UbG674E", "uri": "https://www.assolombarda.it/servizi/internazionalizzazione/documenti/grecia-bando-gestione-parco-olimpico-markopoulo-2022", "label": "Term Lease", "score": 13.2655715942, "published": false}], "hash": "c1cd2bf5ae9a5dd31ff232e26f506528", "id": 9}, {"snippet_links": [{"key": "equal-to", "type": "definition", "offset": [16, 24]}, {"key": "closing-net-working-capital-shortfall", "type": "definition", "offset": [56, 93]}, {"key": "closing-net-working-capital-surplus", "type": "definition", "offset": [118, 153]}, {"key": "company-cash", "type": "definition", "offset": [177, 189]}, {"key": "transaction-expenses", "type": "definition", "offset": [205, 225]}, {"key": "company-debt", "type": "definition", "offset": [267, 279]}, {"key": "the-series", "type": "definition", "offset": [292, 302]}], "snippet": "means an amount equal to (i) $60,000,000 minus (ii) the Closing Net Working Capital Shortfall, if any, plus (iii) the Closing Net Working Capital Surplus, if any, plus (iv) the Company Cash, minus (v) any Transaction Expenses unpaid as of the Closing, minus (vi) any Company Debt minus (vii) the Series G-1 Consideration.", "size": 1, "samples": [{"hash": "8MPgfYJvUJq", "uri": "/contracts/8MPgfYJvUJq#upfront-consideration", "label": "Agreement and Plan of Merger (Soundhound Ai, Inc.)", "score": 36.6878852844, "published": true}], "hash": "60d8bb1a146b9c4764f3e05e7f901531", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIedXBmcm9udC1jb25zaWRlcmF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"title": "Upfront Consideration", "size": 39, "snippet": "has the meaning given to it in clause 3.2;", "id": "upfront-consideration", "examples": ["The <strong>Upfront Consideration</strong> shall be noncreditable, nonrefundable and not subject to set-off."], "related": [["net-consideration", "Net Consideration", "Net Consideration"], ["base-consideration", "Base Consideration", "Base Consideration"], ["contract-consideration", "Contract Consideration", "Contract Consideration"], ["earnout-consideration", "Earnout Consideration", "Earnout Consideration"], ["unit-consideration", "Unit Consideration", "Unit Consideration"]], "related_snippets": [], "updated": "2026-03-14T06:33:37+00:00"}, "json": true, "cursor": ""}}